litlas
Log inCreate account

Jeffrey A. Johnson

Active 1987–2024

73
Papers
17,978
Citations
65
h-index
71
i10-index

Citations

Citations per year for Jeffrey A. Johnson1988: 1 citations1993: 5 citations1994: 1 citations1995: 4 citations1996: 2 citations1997: 3 citations1998: 3 citations1999: 3 citations2000: 7 citations2001: 5 citations2002: 21 citations2003: 51 citations2004: 108 citations2005: 104 citations2006: 137 citations2007: 154 citations2008: 189 citations2009: 266 citations2010: 329 citations2011: 317 citations2012: 317 citations2013: 288 citations2014: 276 citations2015: 316 citations2016: 271 citations2017: 246 citations2018: 177 citations2019: 672 citations2020: 880 citations2021: 764 citations2022: 473 citations2023: 311 citations2024: 433 citations2025: 224 citations2026: 7 citations1989–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,460 citing papers, 30.2% of this breakdownChina: 892 citing papers, 11% of this breakdownUnited Kingdom: 509 citing papers, 6.2% of this breakdownItaly: 324 citing papers, 4% of this breakdownGermany: 250 citing papers, 3.1% of this breakdownJapan: 239 citing papers, 2.9% of this breakdownIndia: 223 citing papers, 2.7% of this breakdownSouth Korea: 223 citing papers, 2.7% of this breakdownCanada: 218 citing papers, 2.7% of this breakdownSpain: 218 citing papers, 2.7% of this breakdownFrance: 171 citing papers, 2.1% of this breakdownSwitzerland: 131 citing papers, 1.6% of this breakdown
0%30.2%Other 28.1%

Institutions

Fields

  • Medicine43.4%
  • Biochemistry, Genetics and Molecular Biology34.9%
  • Neuroscience9.6%
  • Immunology and Microbiology2.4%
  • Mathematics1.9%
  • Pharmacology, Toxicology and Pharmaceutics1.8%
  • Other6%

Topics

  • Genomics, phytochemicals, and oxidative stress9.5%
  • HIV/AIDS Research and Interventions4.3%
  • Neuroinflammation and Neurodegeneration Mechanisms3.6%
  • Alzheimer's disease research and treatments2.8%
  • Glutathione Transferases and Polymorphisms2.4%
  • HIV, Drug Use, Sexual Risk1.9%
  • Other75.5%

Coauthors

All papers

Open in search
  1. Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology

    Authors: Zoeb Jiwaji, Sachin S. Tiwari, Rolando Xavier Aviles‐Reyes, Monique Hooley, David W. Hampton, Megan Torvell, Delinda A. Johnson, Jamie McQueen, Paul Baxter, Kayalvizhi Sabari-Sankar, Jing Qiu, Xin He, Jill H. Fowler, James A. Febery, Jenna M. Gregory, Jamie Rose, Jane Tulloch, James JM Loan, David Story, Karina McDade, Amy Smith, Peta Greer, Matt Ball, Peter C. Kind, Paul M. Matthews, Colin Smith, Owen Dando, Tara L. Spires‐Jones, Jeffrey A. Johnson, Siddharthan Chandran, Giles E. Hardingham - Nature Communications 2022 cited by 232

  2. Astrocyte-oligodendrocyte interaction regulates central nervous system regeneration

    Authors: Irene Molina-González, R. Holloway, Zoeb Jiwaji, Owen Dando, Sarah Kent, Katie Emelianova, Amy Lloyd, Lindsey H. Forbes, Ayisha Mahmood, Thomas Skripuletz, Viktoria Gudi, James A. Febery, Jeffrey A. Johnson, Jill H. Fowler, Tanja Kuhlmann, Anna Williams, Siddharthan Chandran, Martin Stangel, Andrew J.M. Howden, Giles E. Hardingham, Véronique E. Miron - Nature Communications 2023 cited by 164

  3. Coordinate Regulation of Glutathione Biosynthesis and Release by Nrf2-Expressing Glia Potently Protects Neurons from Oxidative Stress

    Authors: Andy Y. Shih, Delinda A. Johnson, Gloria Wong, Andrew D. Kraft, Lei Jiang, Heidi Erb, Jeffrey A. Johnson, Timothy H. Murphy - Journal of Neuroscience 2003 cited by 782

  4. Nrf2—a therapeutic target for the treatment of neurodegenerative diseases

    Authors: Delinda A. Johnson, Jeffrey A. Johnson - Free Radical Biology and Medicine 2015 cited by 320

  5. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

    Authors: Michael C. Thigpen, Poloko Kebaabetswe, Lynn Paxton, Dawn K. Smith, Charles E. Rose, Tebogo Segolodi, Faith L. Henderson, Sonal Pathak, Fatma Soud, Kata Chillag, Rodreck Mutanhaurwa, Lovemore Ian Chirwa, Michael Kasonde, Daniel S. Abebe, Evans Buliva, Roman Gvetadze, Sandra Johnson, Thom Sukalac, Vasavi Thomas, Clyde E. Hart, Jeffrey A. Johnson, C. Kevin Malotte, Craig W. Hendrix, John T. Brooks - New England Journal of Medicine 2012 cited by 2,023

  6. Identification of the NF-E2-related Factor-2-dependent Genes Conferring Protection against Oxidative Stress in Primary Cortical Astrocytes Using Oligonucleotide Microarray Analysis

    Authors: Jong‐Min Lee, Marcus J. Calkins, Kaimin Chan, Yuet Wai Kan, Jeffrey A. Johnson - Journal of Biological Chemistry 2003 cited by 785

  7. Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseases

    Authors: Li Gan, Jeffrey A. Johnson - Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2014 cited by 284

  8. Nrf2 Activation in Astrocytes Protects against Neurodegeneration in Mouse Models of Familial Amyotrophic Lateral Sclerosis

    Authors: Marcelo R. Vargas, Delinda A. Johnson, Daniel W. Sirkis, Albee Messing, Jeffrey A. Johnson - Journal of Neuroscience 2008 cited by 475

  9. The Nrf2–ARE Pathway

    Authors: Jeffrey A. Johnson, Delinda A. Johnson, Andrew D. Kraft, Marcus J. Calkins, Rebekah J. Jakel, Marcelo R. Vargas, Pei‐Chun Chen - Annals of the New York Academy of Sciences 2008 cited by 587

  10. An Important Role of Nrf2-ARE Pathway in the Cellular Defense Mechanism

    Authors: Jong‐Min Lee, Jeffrey A. Johnson - BMB Reports 2004 cited by 749

  11. Increased Alzheimer's disease–like pathology in the APP/ PS1ΔE9 mouse model lacking Nrf2 through modulation of autophagy

    Authors: Gururaj Joshi, Kok Ann Gan, Delinda A. Johnson, Jeffrey A. Johnson - Neurobiology of Aging 2014 cited by 178

  12. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte

    Authors: Pei‐Chun Chen, Marcelo R. Vargas, Amar K. Pani, Richard J. Smeyne, Delinda A. Johnson, Yuet Wai Kan, Jeffrey A. Johnson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2009 cited by 579

  13. Nuclear Factor E2-Related Factor 2-Dependent Antioxidant Response Element Activation bytert-Butylhydroquinone and Sulforaphane Occurring Preferentially in Astrocytes Conditions Neurons against Oxidative Insult

    Authors: Andrew D. Kraft, Delinda A. Johnson, Jeffrey A. Johnson - Journal of Neuroscience 2004 cited by 542

  14. The Absence of the Pro-antioxidant Transcription Factor Nrf2 Exacerbates Experimental Autoimmune Encephalomyelitis

    Authors: Delinda A. Johnson, Sara Amirahmadi, Charlotte Ward, Zsuszanna Fabry, Jeffrey A. Johnson - Toxicological Sciences 2009 cited by 204

  15. Transmitted Drug Resistance Among Human Immunodeficiency Virus (HIV)-1 Diagnoses in the United States, 2014–2018

    Authors: R. Paul McClung, Alexandra M. Oster, M. Cheryl Bañez Ocfemia, Neeraja Saduvala, Walid Heneine, Jeffrey A. Johnson, Ángela Hernández - Clinical Infectious Diseases 2021 cited by 91

  16. The Nrf2/ARE Pathway as a Potential Therapeutic Target in Neurodegenerative Disease

    Authors: Marcus J. Calkins, Delinda A. Johnson, Jessica Townsend, Marcelo R. Vargas, James A. Dowell, Tracy P. Williamson, Andrew D. Kraft, Jong‐Min Lee, Jiang Li, Jeffrey A. Johnson - Antioxidants and Redox Signaling 2008 cited by 445

  17. The Nrf2–ARE cytoprotective pathway in astrocytes

    Authors: Marcelo R. Vargas, Jeffrey A. Johnson - Expert Reviews in Molecular Medicine 2009 cited by 290

  18. Nrf2, a multi‐organ protector?

    Authors: Jongmin Lee, Jiang Li, Delinda A. Johnson, Thor D. Stein, Andrew D. Kraft, Marcus J. Calkins, Rebekah J. Jakel, Jeffrey A. Johnson - The FASEB Journal 2005 cited by 527

  19. Inhibiting the Keap1/Nrf2 Protein‐Protein Interaction with Protein‐Like Polymers

    Authors: Kendal P. Carrow, H. Hamilton, Madeline P. Hopps, Yang Li, Baofu Qiao, N. Connor Payne, Matthew P. Thompson, Xiaoyu Zhang, Assa Magassa, Mara Fattah, Shivangi Agarwal, Michael P. Vincent, Marina Buyanova, Paul A. Bertin, Ralph Mazitschek, Mónica Olvera de la Cruz, Delinda A. Johnson, Jeffrey A. Johnson, Nathan C. Gianneschi - Advanced Materials 2024 cited by 28

  20. Pharmacodynamic characterization of chemopreventive triterpenoids as exceptionally potent inducers of Nrf2-regulated genes

    Authors: Melinda S. Yates, Masafumi Tauchi, Fumiki Katsuoka, Kathleen C. Flanders, Karen T. Liby, Tadashi Honda, Gordon W. Gribble, Delinda A. Johnson, Jeffrey A. Johnson, Neal C. Burton, Tomás R. Guilarte, Masayuki Yamamoto, Michael B. Sporn, Thomas W. Kensler - Molecular Cancer Therapeutics 2007 cited by 293

  21. The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases

    Authors: Gururaj Joshi, Jeffrey A. Johnson - Recent Patents on CNS Drug Discovery 2012 cited by 245

  22. Astrocyte-Specific Overexpression of Nrf2 Delays Motor Pathology and Synuclein Aggregation throughout the CNS in the Alpha-Synuclein Mutant (A53T) Mouse Model

    Authors: Li Gan, Marcelo R. Vargas, Delinda A. Johnson, Jeffrey A. Johnson - Journal of Neuroscience 2012 cited by 179

  23. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription

    Authors: Marcus J. Calkins, Rebekah J. Jakel, Delinda A. Johnson, Kaimin Chan, Yuet Wai Kan, Jeffrey A. Johnson - National Academy of Sciences, Proceedings of the National Academy of Sciences 2004 cited by 250

  24. The PPAR-γ agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeys

    Authors: Christine R. Swanson, Valerie Joers, Viktoriya Bondarenko, Kevin Brunner, Heather A. Simmons, Toni E. Ziegler, Joseph W. Kemnitz, Jeffrey A. Johnson, Marina E. Emborg - Journal of Neuroinflammation 2011 cited by 185